Nordic Nanovector
Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
Launch date
Employees
Market cap
€32.2m
Enterprise valuation
€23m (Public information from Jun 2023)
Share price
NOK1.018 NANOV.F
Oslo Norway (HQ)
Authorizing premium user...